×
模态框(Modal)标题
在这里添加一些文本
Close
Close
Submit
Cancel
Confirm
×
模态框(Modal)标题
×
导航切换
Home
About Journal
Editorial Board
Policies & Guidelines
Instruction to Authors
Ethics Statement
Review Policy & Process
Copyright & OA
Advertising Policy
Data Sharing Policy
Corrections & Retractions
Subscribe
Contact Us
中文
Figure/Table detail
Clinical study on low-dose rituximab maintenance therapy in children with primary nephrotic syndrome
Wen-Ting PENG, Xiao-Zhong LI
Chinese Journal of Contemporary Pediatrics
, 2025, 27(
8
): 982-988. DOI:
10.7499/j.issn.1008-8830.2409131
预后情况
3个月 (
n
=70)
6个月 (
n
=70)
12个月 (
n
=66)
18个月 (
n
=53)
24个月 (
n
=38)
36个月 (
n
=23)
维持缓解率
70(100)
66(94)
58(88)
44(83)
32(84)
17(74)
临床缓解率
70(100)
66(94)
61(92)
52(98)
38(100)
23(100)
复发率
0(0)
4(6)
5(8)
1(2)
0(0)
0(0)
表1
治疗后患儿的临床预后情况 [
n
(%)]
Other figure/table from this article
表2
RTX治疗前与治疗后各时间点的指标变化比较
表3
每剂使用RTX后B细胞重建时间 [
M
(
P
25
,
P
75
),月]
图1
RTX治疗前与治疗后各时间点的激素及TAC的使用剂量对比 *示治疗后各时间点的药物用量与治疗前比较,
P
<0.05。
表4
尿蛋白阴性组与尿蛋白阳性组间相关指标比较
表5
尿蛋白转阳危险因素的多因素logistic回归分析